Cencora, Inc. $COR Position Lowered by Boston Partners

Boston Partners lessened its stake in shares of Cencora, Inc. (NYSE:COR) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,196,536 shares of the company’s stock after selling 312,629 shares during the period. Cencora accounts for approximately 1.5% of Boston Partners’ portfolio, making the stock its 2nd biggest position. Boston Partners owned about 2.16% of Cencora worth $1,418,420,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of COR. Oakworth Capital Inc. purchased a new position in shares of Cencora during the 4th quarter worth $26,000. Elyxium Wealth LLC purchased a new position in shares of Cencora during the 4th quarter worth $27,000. Archer Investment Corp raised its holdings in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the period. IAG Wealth Partners LLC purchased a new position in shares of Cencora during the 3rd quarter worth $30,000. Finally, Caitlin John LLC purchased a new position in shares of Cencora during the 3rd quarter worth $31,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on COR shares. Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, May 22nd. Barclays decreased their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday. UBS Group upped their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Finally, Evercore set a $360.00 price target on Cencora in a research note on Wednesday, April 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $374.00.

Cencora Stock Up 0.0%

Shares of NYSE COR opened at $281.56 on Friday. The firm has a market cap of $54.78 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 1.52 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 52-week low of $244.82 and a 52-week high of $377.54. The business’s 50 day moving average is $289.22 and its two-hundred day moving average is $327.63.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts predict that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora announced that its Board of Directors has authorized a stock repurchase program on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.